Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

61 ta ish

Ish: COVID-19: well-known drugs, new opportunities

  1. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

    Dawei Wang, Bo Hu, Chang Hu +11

    MaqolaOchiq kirish202015 iqtibos
    ABI

  2. La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

    Martínez González, Marina

    Maqola202014 iqtibos
    ABI

  3. A pneumonia outbreak associated with a new coronavirus of probable bat origin

    Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang +26

    MaqolaOchiq kirish202014 iqtibos
    ABI

  4. A Novel Coronavirus from Patients with Pneumonia in China, 2019

    Na Zhu, Dingyu Zhang, Wenling Wang +15

    MaqolaOchiq kirish202013 iqtibos
    ABI

  5. Correspondence - Tranexamic acid for traumatic brain injury

    Sasieni, Peter D; id_orcid 0000-0003-1509-8744, Duffy, Stephen W, Cuzick, Jack

    Maqola200512 iqtibos
    ABI

  6. COVID-19: consider cytokine storm syndromes and immunosuppression

    Puja Mehta, Daniel F. McAuley, Michael Brown +3

    Maqola20206 iqtibos
    ABI

  7. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

    Manli Wang, Ruiyuan Cao, Leike Zhang +7

    Boshqa20205 iqtibos
    ABI

  8. Sarlavhasiz

    Boshqa4 iqtibos
    ABI

  9. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

    Jérôme R. Lechien, Carlos M. Chiesa‐Estomba, Daniele R. de Siati +30

    Maqola20204 iqtibos
    ABI

  10. Emerging coronaviruses: Genome structure, replication, and pathogenesis

    Yu Chen, Qianyun Liu, Deyin Guo

    Sharh maqola20203 iqtibos
    ABI

  11. Coronavirus infections and immune responses

    Geng Li, Yaohua Fan, Yanni Lai +9

    Sharh maqola20203 iqtibos
    ABI

  12. Sarlavhasiz

    Boshqa3 iqtibos
    ABI

  13. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

    Andrea Cortegiani, Giulia Ingoglia, Mariachiara Ippolito +2

    Sharh maqola20203 iqtibos
    ABI

  14. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

    Martin J. Vincent, Éric Bergeron, Suzanne Benjannet +5

    Maqola20052 iqtibos
    ABI

  15. RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

    Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola +15

    Maqola20202 iqtibos
    ABI

  16. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

    Shutoku Matsuyama, Naganori Nao, Kazuya Shirato +15

    Maqola20202 iqtibos
    ABI

  17. Vitamin D and the Immune System

    Cynthia Aranow

    Sharh maqola20112 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  19. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

    Markus Hoffmann, Hannah Kleine‐Weber, Nadine Krüger +3

    Preprint20202 iqtibos
    ABI

  20. Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV

    Jared S. Morse, Tyler Lalonde, Shiqing Xu +1

    Maqola20202 iqtibos
    ABI

  21. Discovering drugs to treat coronavirus disease 2019 (COVID-19)

    Liying Dong, Shasha Hu, Jianjun Gao

    Maqola20202 iqtibos
    ABI

  22. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus

    Miguel Ángel Martı́nez

    Sharh maqola20202 iqtibos
    ABI

  23. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

    Philippe Colson, Jean‐Marc Rolain, Jean‐Christophe Lagier +2

    Boshqa20202 iqtibos
    ABI

  24. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence

    Yuchen Cao, Qixin Deng, Shixue Dai

    Sharh maqola20202 iqtibos
    ABI

  25. Dapsone and doxycycline could be potential treatment modalities for COVID-19

    Ahmed Farouk, Samar Salman

    Boshqa20202 iqtibos
    ABI